Warp Sciences, founded by ex-OpenAI product chief Kevin Weil to speed up AI drug development, emerges from stealth with $215M at an $865M post-money valuation (Rebecca Torrence/Bloomberg)

Warp Sciences, founded by former OpenAI product chief Kevin Weil, has emerged from stealth with $215 million in funding at an $865 million post-money valuation. The startup aims to accelerate AI-driven drug development, building on Weil's previous leadership of AI-for-science efforts at OpenAI.